![Ryan Arnold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Arnold
Corporate Officer/Principal chez
STOKE THERAPEUTICS, INC.
Profil
Ryan Arnold is currently Senior VP & Head-Global Medical Affairs at Stoke Therapeutics, Inc. Former positions include Chief Medical Officer at BioCryst Pharmaceuticals, Inc. from 2022 to 2024, Vice President-Medical Affairs at SAGE Therapeutics, Inc., and Principal at Biogen, Inc. Education includes a doctorate from Michigan State University and an undergraduate degree from Oakland University (Michigan).
Postes actifs de Ryan Arnold
| Sociétés | Poste | Début |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Ryan Arnold
| Sociétés | Poste | Fin |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 05/09/2024 |
| BIOGEN INC. | Corporate Officer/Principal | - |
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Ryan Arnold
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oakland University (Michigan)
 Oakland University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
